Baseline characteristics, clinical data and self-rated health, internal consistency, and test of differences between intervention and control group (p value)
Intervention group (n=103) | Control group (n=104) | P value | |
Men, n (%) | 58 (56) | 51 (49) | 0.364* |
Age, n | 103 | 104 | 0.500† |
Mean (SD) | 75.3 (10.1) | 74.3 (10.8) | 95% CI −1.89 to 3.86 |
Median (Q1–Q3) | 77 (69–82) | 75 (68–83) | |
Having social support, n (%) | 75 (73) | 74 (71) | 0.358* |
Income (SEK), n (%) | 0.169* | ||
<10 000 | 4 (4) | 9 (9) | |
10 000–20 000 | 32 (31) | 43 (41) | |
20 000–50 000 | 34 (33) | 24 (23) | |
>50 000 | 8 (8) | 8 (8) | |
Education, n (%) | 0.553* | ||
< 9 years | 5 (5) | 6 (6) | |
Primary school (9 years) | 21 (20) | 17 (16) | |
Secondary school | 26 (25) | 39 (38) | |
University | 28 (27) | 23 (22) | |
Country of birth, n (%) | 0.901* | ||
Sweden | 70 (68) | 71 | |
Nordic country other than Sweden | 6 (6) | 5 (5) | |
Outside the Nordic countries | 5 (5) | 8 (8) | |
CCI, n | 94 | 91 | 0.049† |
Mean (SD) | 6.2 (2.0) | 5.7 (2.0) | 95% CI 0.003 to 1.15 |
Median (Q1–Q3) | 6 (5–7) | 6 (5–7) | |
PHQ-9 (α=0.82), n | 73 | 80 | 0.412* |
Mean (SD) | 8.5 (5.2) | 9.1 (6.5) | |
Median (Q1–Q3) | 8 (5–12) | 8 (4–13) | |
EQ (α=0.76), n | 78 | 86 | 0.744* |
Mobility | |||
Median (Q1–Q3) | 3 (2–4) | 3 (2–4) | |
Self-care | 78 | 86 | 0.392* |
Median (Q1–Q3) | 1 (1–2) | 1 (1–2) | |
Usual activity | 77 | 87 | 0.754* |
Median (Q1–Q3) | 3 (2–4) | 2 (2–4) | |
Pain/discomfort | 78 | 86 | 0.331* |
Median (Q1–Q3) | 3 (2–3) | 3 (2–3) | |
Anxiety/depression | 77 | 87 | 0.806* |
Median (Q1–Q3) | 2 (1–3) | 2 (1–3) |
If the numbers in some columns do not add up to 104 or 103, it is because some of the participants did not respond. Significant p values are highlighted in bold.
*χ2 test for independence.
†Independent samples t-test.
CCI, age-adjusted Charlson Comorbidity Index; EQ EQ-5D-5L, European Quality of Life 5 Dimensions 5 Levels; PAM, Patient Activation Measure-13-S; PHQ-9, Patient Health Questionnaire; Q, quartile; SEK, Swedish krona; α, Cronbach’s alpha.